Dr. Lin Z. Li's research lab focuses on developing advanced imaging techniques to enhance the prognosis of early-stage triple negative breast cancer. By using a method called Optical Redox Imaging, the lab aims to identify metabolic variations within tumors that could inform treatment strategies and improve patient outcomes. Their work is essential for creating better diagnostic tools that predict disease progression, leading to more personalized treatment approaches for cancer patients.

Dr. David Cormode's lab at the University of Pennsylvania focuses on enhancing breast cancer screening techniques using advanced materials. They are developing silver telluride nanoparticles as contrast agents for dual-energy mammography, aimed at improving tumor detection, especially in women with dense breast tissue. This research combines innovative nanoparticle technology with clinical applications to aim for better outcomes in breast cancer detection and treatment.

David Mankoff's lab focuses on understanding how certain aggressive cancers, particularly triple-negative breast cancer, utilize glutamine metabolism and glutamate transport to survive and resist treatment. They are developing advanced imaging techniques using positron emission tomography (PET) to measure these metabolic processes and to identify patients who may benefit from specific therapies targeting these pathways. By linking imaging data to treatment response, the lab aims to improve personalized cancer therapies and outcomes for patients.

Dr. Witschey's lab at the University of Pennsylvania focuses on understanding and improving treatments for heart problems, especially those caused by blockages in blood flow. They care deeply about identifying ways to detect and analyze damage that occurs after blood flow is restored to the heart, which can paradoxically cause additional harm. Through advanced imaging techniques, the lab aims to study ‘reactive oxygen species’ that help track the heart's recovery process after a heart attack, ultimately enhancing clinical outcomes for patients.

Dr. Surbhi Grover's lab at the University of Pennsylvania focuses on improving cancer care in low- and middle-income countries, with a specific emphasis on addressing delays in treatment for cervical cancer in Botswana. The research seeks to identify practical strategies that enable timely treatment after diagnosis by analyzing barriers and enhancing communication and care coordination. Through innovative study designs, the lab aims to create sustainable solutions that improve health outcomes for women facing cervical cancer, especially in contexts with high HIV prevalence.

Dr. Timothy C. Zhu's lab at the University of Pennsylvania focuses on improving cancer treatment through advanced imaging techniques. The lab is developing Cherenkov imaging, which uses light emitted from tissue during radiation therapy to create real-time maps of the radiation dose delivered to patients' skin. This innovative approach aims to enhance the precision of total skin electron therapy (TSET) for patients suffering from conditions like mycosis fungoides, ensuring that they receive the correct dose and improving treatment outcomes.

Dr. Andrea Facciabene leads innovative research at the University of Pennsylvania focusing on cancer treatment, specifically exploring the combination of radiation therapy with T-cell therapy and modifications of the gut microbiome. Their work seeks to enhance antitumor responses in patients with lymphomas and lung cancer, aiming to redefine treatment strategies to prolong patients' survival. By studying how gut bacteria can impact cancer therapies, the lab is at the forefront of novel cancer treatment research that could lead to groundbreaking advancements in oncology.

Dr. Yi Fan's lab at the University of Pennsylvania focuses on understanding glioblastoma, a highly aggressive brain tumor, and how it resists treatments. The research aims to explore the role of specialized cells in the tumor's blood supply and their influence on the immune response, potentially paving the way for innovative therapies that could improve patient outcomes.

Dr. Yong Fan's lab at the University of Pennsylvania focuses on using advanced artificial intelligence and machine learning techniques to study how the brain develops and functions. The research aims to improve our understanding of brain development variability in youth through the analysis of large-scale brain imaging data. By creating interpretable models and tools, the lab seeks to provide insights into individual differences in cognition and psychopathology, ultimately guiding personalized treatment approaches for brain disorders.

Dr. James C. Gee's lab at the University of Pennsylvania focuses on enhancing imaging technologies in biomedical research. Their main project, the Advanced Normalization Tools (ANTs), is an open-source software library that offers powerful tools for image processing and analysis, benefiting researchers across various fields. The lab aims to modernize and expand this toolkit to support complex imaging needs and meet the growing demands of the scientific community.

Dr. Mohammad Haris's lab focuses on understanding Alzheimer's disease by exploring the role of neuroinflammation and developing new imaging methods to monitor it. Their research aims to connect neuroinflammation to disease progression and metabolic changes in the brain through innovative techniques. By working with mouse models and advanced magnetic resonance spectroscopy methods, they hope to create new diagnostic tools that can improve how we detect and treat Alzheimer's disease.

Dr. Ragini Verma's lab at the University of Pennsylvania focuses on improving surgical outcomes for patients with high-grade gliomas, a type of aggressive brain cancer. The lab is developing innovative tools that use advanced imaging techniques to help surgeons accurately locate and remove both visible and infiltrative tumor tissue while preserving important brain functions. This research aims to increase survival rates for patients by enhancing pre-operative planning and minimizing neurological deficits after surgery.

Dr. Joel S. Karp's lab at the University of Pennsylvania focuses on enhancing cancer imaging techniques using advanced PET (Positron Emission Tomography) and CT (Computed Tomography) technologies. The research aims to develop innovative scan protocols and detector designs to improve diagnostic accuracy while reducing patient burden through shorter imaging times. By integrating dynamic imaging methods, the lab seeks to provide better insights into cancer biology and improve patient outcomes via enhanced imaging protocols.

Dr. Alex Hughes' lab at the University of Pennsylvania focuses on developing engineered kidney tissues by manipulating stem cells to produce nephrons in a controlled, rhythmic manner. The research aims to understand the natural processes that facilitate kidney development and replicate those mechanisms in lab-grown tissues. By improving the scale and efficiency of nephron production, this work has the potential to revolutionize treatments for kidney failure and related diseases.

Dr. Mark A. Sellmyer's lab at the University of Pennsylvania focuses on developing innovative methods to control protein functions within living organisms for research in cancer therapy. They are particularly interested in how proteins can be tagged and regulated using small molecules, which allows for advanced imaging techniques to visualize these processes in real time. This work includes creating technologies that can improve treatments, like CAR T-cell therapies, by optimizing how these therapeutic proteins behave inside the body.

Dr. Terence Gade's lab at the University of Pennsylvania focuses on improving diagnosis and treatment of liver cancer, particularly hepatocellular carcinoma (HCC). They work on developing advanced imaging techniques and patient-derived models to better understand tumor behavior and predict treatment responses. This research aims to enhance patient outcomes by creating more effective therapies based on personalized data from these models.

Dr. Robert H. Mach's lab at the University of Pennsylvania focuses on advancing our understanding of neurodegenerative diseases by developing advanced imaging techniques. In particular, the lab is working on creating new Positron Emission Tomography (PET) ligands that help visualize protein clumps associated with conditions like Parkinson's disease and frontotemporal dementia. Through collaborations with top universities, the lab aims to improve diagnostic methods and therapeutics for these critical neurological disorders.

Dr. Peter B. Noel's lab focuses on improving medical imaging technologies, particularly in the area of computed tomography (CT) and x-ray imaging. They are developing innovative approaches, such as 3D printing patient-specific CT phantoms to enhance the accuracy of imaging devices. Additionally, they are researching advanced imaging techniques to detect early changes in lung structure due to radiation therapy, with the aim of improving patient care outcomes.

Dr. Kavindra Nath's lab at the University of Pennsylvania focuses on improving cancer treatment monitoring through advanced imaging techniques. They study how targeted therapies, particularly those affecting metabolism in cancer cells, can be evaluated non-invasively. By analyzing metabolic changes in cancer cells, specifically in diffuse large B-cell lymphoma, the lab aims to provide earlier assessments of treatment effectiveness without the need for invasive procedures like biopsies.

Dr. Zhiliang Cheng's lab at the University of Pennsylvania focuses on developing innovative treatments for osteoarthritis (OA), which is a debilitating joint disease. The lab aims to create dual-action nanoparticles that can effectively deliver therapies to restore cartilage health and reduce joint pain. By using both in vitro and animal models, the research aims to provide solutions that may improve the quality of life for those affected by OA and other degenerative joint diseases.